AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2025
Feb 26, 2025
32559_dirs_2025-02-25_1ca93ef9-a3bc-4aa6-8cb4-cb75bc6afc14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-02-24
Reporting Person: Gengos Andrew (N/A)